Table 4 Factors affecting cognitive impairment after sedation using linear regression analysis.

From: Safety profile of sedative endoscopy including cognitive performance in liver cirrhosis: A double-blind randomized controlled trial

Variable

Univariable

Multivariable

B (SE)

P value

B (SE)

P value

Age

4.29 (1.12)

<0.001

4.20 (0.91)

<0.001

Sex

    Female

1 (Ref)

   

    Male

1.33 (31.16)

0.966

  

ASA class

    I

1 (Ref)

 

1 (Ref)

 

    II

72.97 (23.15)

0.003

32.06 (17.43)

0.071

Education level

    High-educated (≥9 years)

1 (Ref)

 

1 (Ref)

 

    Low-educated (<9 years)

118.20 (27.02)

<0.001

85.17 (20.99)

<0.001

Etiology

    Non-alcohol

1 (Ref)

   

    Alcohol

28.46 (24.87)

0.257

  

Ascites

    None

1 (Ref)

 

1 (Ref)

 

    Mild to moderate

62.43 (26.81)

0.023

−8.17 (21.13)

0.700

    Severe

83.10 (29.88)

0.007

31.57 (22.24)

0.162

MELD score

7.53 (2.34)

0.002

7.59 (1.84)

<0.001

Esophageal varices

      No

1 (Ref)

   

      F1

30.97 (38.04)

0.419

  

      F2

35.73 (36.23)

0.328

  

      F3

33.85 (53.33)

0.528

  

Gastric varices

    No

1 (Ref)

   

    Present

−12.97 (30.21)

0.669

  

Sedative drug

    Midazolam only

1 (Ref)

   

    Propofol only

−3.61 (30.52)

0.906

  

    Midazolam + Propofol

25.07 (0.52)

0.415

  
  1. Abbreviations: B, beta coefficients; SE, standard error; ASA class, American Society of Anesthesiologists Classification; MELD, Model for End-Stage Liver Disease.